Research
Print page Print page
Switch language
Bispebjerg Hospital - a part of Copenhagen University Hospital
Published

ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Day-to-day measurement of physical activity and risk of atrial fibrillation

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Driving following defibrillator implantation: a nationwide register-linked survey study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and Cons

    Research output: Contribution to journalReviewResearchpeer-review

  2. Socioeconomic disparity in cardiovascular disease: Possible biological pathways based on a proteomic approach

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Global and regional wall motion abnormalities and incident heart failure in the general population

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Atrial cardiomyopathy in patients with ischaemic stroke: a cross-sectional and prospective cohort study-the COAST study

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Task Force for the management of COVID-19 of the European Society of Cardiology
  • Eva Irene Bossano Prescott (Member of study group)
View graph of relations

AIMS: Since its emergence in early 2020, the novel severe acute respiratory syndrome coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels, and there have been repeated outbreaks across the globe. The aim of this two part series is to provide practical knowledge and guidance to aid clinicians in the diagnosis and management of cardiovascular (CV) disease in association with COVID-19.

METHODS AND RESULTS: A narrative literature review of the available evidence has been performed, and the resulting information has been organized into two parts. The first, which was reported previously, focused on the epidemiology, pathophysiology, and diagnosis of CV conditions that may be manifest in patients with COVID-19. This second part addresses the topics of: care pathways and triage systems and management and treatment pathways, both of the most commonly encountered CV conditions and of COVID-19; and information that may be considered useful to help patients with CV disease (CVD) to avoid exposure to COVID-19.

CONCLUSION: This comprehensive review is not a formal guideline but rather a document that provides a summary of current knowledge and guidance to practicing clinicians managing patients with CVD and COVID-19. The recommendations are mainly the result of observations and personal experience from healthcare providers. Therefore, the information provided here may be subject to change with increasing knowledge, evidence from prospective studies, and changes in the pandemic. Likewise, the guidance provided in the document should not interfere with recommendations provided by local and national healthcare authorities.

Original languageEnglish
JournalEuropean Heart Journal
Volume43
Issue number11
Pages (from-to)1059-1103
Number of pages45
ISSN0195-668X
DOIs
Publication statusPublished - 14 Mar 2022

Bibliographical note

This article has been co-published with permission in the European Heart Journal and Cardiovascular Research. © The European Society of Cardiology 2021. All rights reserved. The articles are identical except for minor stylistic and spelling differences in keeping with each journal’s style. Either citation can be used when citing this article.

ID: 74537747